Mflusiva Injection, Suspension
Product Images NDC 80777-500

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mflusiva (NDC 80777-500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Moderna Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mflusiva (influenza Vaccine, Mrna) 2026-2027 Formula Injectable Suspension For Intramuscular Use Single-dose Pre-filled Syringe 0.38 mL (Image 01)

Label for mFLUSIVA Influenza Vaccine, mRNA, 0.38 mL single-dose injection suspension by Moderna US, Inc. The label shows the product name, formula year 2026-2027, NDC 80777-500-18, with spaces for lot and expiration dates, and indicates the vaccine is for intramuscular use and prescription only.*

FDA Label Image

Mflusiva (influenza Vaccine, Mrna) 2026-2027 Formula Injectable Suspension For Intramuscular Use Single-dose Pre-filled Syringe Carton 0.38 mL (Image 02)

Carton packaging label for mFLUSIVA Influenza Vaccine, mRNA 2026-2027 Formula by Moderna US, Inc. It is an injectable suspension for intramuscular use, indicated for adults 50 years and older. Contains 10 single-dose pre-filled syringes, each dose 0.38 mL. The label features the product name, formulation year, dosage form, intended age group, quantity, and the Moderna logo with Rx only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.